Risk of glomerular diseases, proteinuria and hematuria following mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines.

MLA

Cheng, Franco Wing Tak, et al. “Risk of Glomerular Diseases, Proteinuria and Hematuria Following MRNA (BNT162b2) and Inactivated (CoronaVac) SARS-CoV-2 Vaccines.” Nephrology Dialysis Transplantation, vol. 38, no. 1, Jan. 2023, pp. 129–37. EBSCOhost, https://doi.org/10.1093/ndt/gfac292.

APA

Cheng, F. W. T., Wong, C. K. H., Qin, S. X., Chui, C. S. L., Lai, F. T. T., Li, X., Wan, E. Y. F., Chan, E. W., Au, C. H., Ye, X., Tang, S. C. W., & Wong, I. C. K. (2023). Risk of glomerular diseases, proteinuria and hematuria following mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines. Nephrology Dialysis Transplantation, 38(1), 129–137. https://doi.org/10.1093/ndt/gfac292

Chicago

Cheng, Franco Wing Tak, Carlos King Ho Wong, Simon Xiwen Qin, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, Eric Yuk Fai Wan, et al. 2023. “Risk of Glomerular Diseases, Proteinuria and Hematuria Following MRNA (BNT162b2) and Inactivated (CoronaVac) SARS-CoV-2 Vaccines.” Nephrology Dialysis Transplantation 38 (1): 129–37. doi:10.1093/ndt/gfac292.